search

opensafely / antibody-and-antiviral-deployment

While vaccines remain the best strategy to prevent COVID-19, mAbs could potentially benefit certain vulnerable populations before or after exposure to SARS-CoV-2, such as the unvaccinated or recently vaccinated high-risk patients.
MIT License
1 stars 4 forks source link

Eligibility criteria #1

Closed acagreen17 closed 2 years ago

acagreen17 commented 2 years ago

Adding variables to define eligibility criteria.

gitpod-io[bot] commented 2 years ago

acagreen17 commented 2 years ago

@HelenCEBM please could you review the high risk group variable definitions? I'm adding variables to define each high risk group one commit at a time so will be more to come.